Every 37 seconds someone in the western world dies from a Venous thromboembolism (VTE).
Aesthetic Treatments
Are you taking anticoagulants and thinking about having aesthetics treatments then our new fact sheet is a must read before you make a decision to go ahead.
Resources section now available
Anticoagulation UK are pleased to announce the launch of our new online resources section.
Containing leaflets, reports and videos across a variety of topics for both patients and HCP's.
DEVELOPING OPTIMAL STANDARDS OF CARE FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM (VTE): CONSENSUS STATEMENT
New Resource Pack available
ACUK launch toolkit for nurses looking after people with cancer and who want to help prevent cancer associated thrombosis
To order copies of the toolkit please email your name and address to: info@anticoagulationuk.org
Out of range:
Audit of anticoagulation management in secondary care in England
Anticoagulation UK's mission can be simply defined by 3 key objectives:
Film: Let's Talk About Anticoagulation
News & Events
11 July 2019
NHS health information available through Amazon's Alexa
11 July 2019
Getting your medication after we leave the EU
01 July 2019
Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial
28 June 2019
Urgent - Patient level recall
27 June 2019
Eating more vitamin K found to help, not harm, patients on warfarin
27 June 2019
Management of cancer-associated thrombosis in people with advanced disease.
24 June 2019
Nearly three quarters of a million patients set to benefit from world-leading innovations on the NHS
24 June 2019
The European Medicines Agency Pharmacovigilance Risk Assessment committee have issued advice NOT to use DOACs in patients with antiphospholipid syndrome
10 May 2019
Aesthetics Treatments Factsheet - Launched at the All England National Thrombosis Conference - London 2019
28 February 2019
Rivaroxaban (Xarelto) has been accepted by the Scottish Medicines Agency for restricted use within Scotland for the following indication.
Page 1 of 4
Next
Join/Renew
Anticoagulation UK is dedicated to the prevention of thrombosis, raising awareness of the risk of blood clots and how to help prevent them. We rely on the generosity of people like you to help us achieve our mission. Your support really makes a difference.
Newsletter
Take part in research studies and focus groups
Take part in the ACUK Ambassador programme
Tell your story
Get Social
Anticoagulation would love to hear from you.
Keep updated with all our activities by becoming a subscriber
Across our social media platforms....
Your support makes our mission possible
Latest Tweets
FollowSummer is nearly here! If you're headed for a festival or party in the park, don't forget to click via @GiveasyouLive before ordering your essentials; every shop could raise FREE funds for us! > https://t.co/TR3JbcELz7 pic.twitter.com/pwRpXgm0Ma
— ACUK (@AntiCoagUK) July 2, 2019
FollowURGENT Patient recall of certain batches of Clexane used to treat blood clots
— ACUK (@AntiCoagUK) June 28, 2019
If you have any of these affected products you should continue using the medication & contact your GP practice to get a new prescription
Go to https://t.co/RQB2YRd1JR to see the affected batch numbers
FollowA new clinical trial suggests that patients on warfarin benefit from increasing their vitamin K intake as long as they keep their intake levels consistent Vitamin K can be found in foods such as green vegetableshttps://t.co/nMpFvuCGYO via @Pharmacy_Times pic.twitter.com/31N1w5aNFB
— ACUK (@AntiCoagUK) June 27, 2019